Evidence map›Paper›PMID 41309705›Full record

ArticleScientific reports2025

A dendritic nanocatalyst (Fe

Maziar Mirza, Mohammad Ali Bodaghifard, Fatemeh Darvish

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Maziar MirzaDepartment of Organic Chemistry, Faculty of Chemistry, K.N. Toosi University of Technology, Tehran, 15418-49611, Iran.
Mohammad Ali BodaghifardDepartment of Chemistry, Faculty of Science, Arak University, Arak, 38481-77584, Iran. mbodaghi2007@yahoo.com.
Fatemeh DarvishDepartment of Organic Chemistry, Faculty of Chemistry, K.N. Toosi University of Technology, Tehran, 15418-49611, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A novel hybrid nanomagnetic dendrimer-based catalyst was synthesized in this study using trimesoyl chloride and diethylene triamine as building blocks. Various characterization techniques, including FT-IR, XRD, TGA, VSM, BET, SEM, and EDX, confirmed the successful construction of the nanostructure. The first-generation magnetic nanodendrimer catalyst (Fe₃O₄@SiO₂@DETA-TMD-G1) was used to synthesize Pyrano[3,2-c] chromene-3-carbonitrile derivatives in an aqueous medium. This method enhanced product yield (80-96%) and eliminated harmful organic solvents, making the process more sustainable. The catalyst also exhibited excellent magnetic recyclability, maintaining its efficiency over five consecutive reaction cycles. The presence of functionalized dendritic moieties enhanced efficient molecular interactions, leading to improved reaction rates, excellent yields, and higher selectivity for the desired heterocyclic products. By following green chemistry principles, this approach introduces a highly efficient, magnetically recoverable, and environmentally friendly catalytic system, offering a sustainable alternative for the synthesis of biologically active compounds with applications in pharmaceuticals and materials science.

Identifiers

PMID41309705
PMCPMC12660763

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.